Fennec Medical
Orthopedics AI Surgical Assistant that enhances real-time decision-making in the OR
Company Overview
Snapshot
Founded in January 2023 by Nir Karasikov, PhD, Nadav Cohen, and Jim Dick, Fennec Medical operates with 1–10 employees. The company has secured funding across four rounds, including a Pre-Seed round in August 2023. Fennec Medical also received a grant in October 2024, signaling ongoing support for its innovative medical technology.
Business overview
Fennec Medical is a digital surgery company specializing in orthopedic procedures. The company develops an AI Surgical Assistant designed to enhance real-time decision-making within the operating room. Its core technology, the AI Surgical Co-pilot, is powered by Echostem, a wireless, disposable instrument that monitors bone-implant interaction. This system provides continuous, actionable guidance and pre-fracture alerts, aiming to transform orthopedic surgery from a subjective art into a predictable science. Fennec Medical serves the healthcare industry, particularly providers, by addressing the global burden of early mechanical failures in orthopedic procedures and driving cost savings for hospitals.
Log in to access full profile ›Company Intelligence Q&A
- What is Fennec Medical's primary focus?
- Fennec Medical focuses on transforming orthopedic procedures through an AI Surgical Assistant that provides real-time decision-making support in the operating room.
- When was Fennec Medical founded?
- Fennec Medical was founded in January 2023.
- Who are the founders of Fennec Medical?
- Fennec Medical was co-founded by Nir Karasikov, PhD, Nadav Cohen, and Jim Dick.
- What is Echostem?
- Echostem is a wireless, disposable instrument that powers Fennec Medical's AI Surgical Co-pilot by listening to bone-implant interaction, providing continuous guidance and pre-fracture alerts.
- Has Fennec Medical received any grants?
- Yes, Fennec Medical received a grant in October 2024, another in March 2024, and an additional grant in January 2023.